Rigel Pharmaceuticals (RIGL)
(Delayed Data from NSDQ)
$10.21 USD
-0.22 (-2.11%)
Updated Aug 9, 2024 03:59 PM ET
After-Market: $10.20 -0.01 (-0.10%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $0.01 | 0.00% |
Earnings Summary
For their last quarter, Rigel Pharmaceuticals (RIGL) reported earnings of -$0.06 per share, beating the Zacks Consensus Estimate of $-0.37 per share. This reflects a positive earnings surprise of 83.78%. Look out for RIGL's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of $0.01 per share, reflecting a year-over-year increase of 103.33%.
Earnings History
Price & Consensus
Zacks News for RIGL
Profound Medical (PROF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
RIGL: What are Zacks experts saying now?
Zacks Private Portfolio Services